公司資料
Kineta 股價、新聞與催化劑
- 股票代碼:
- KA
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for KA.
公司概覽
業務概覽
Kineta is a biopharmaceutical company focused on immunotherapy and inflammation, with programs aimed at hard-to-treat immune-mediated disease. Its story is built around a narrow but targeted pipeline.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Kineta sits in specialty biotechnology.
商業模式特徵
The company depends on clinical data, target differentiation, and the ability to create a durable immunology franchise.
生技產業定位
Kineta is a small-cap catalyst name whose valuation is tightly tied to early clinical and strategic progress.
未來催化劑
- Kineta’s catalysts are immunology and oncology programs, plus any strategic step that clarifies the company’s direction. The market will care about whether there is still a viable development path.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。